Connor, Clark & Lunn Investment Management Ltd.
Position in TXG — 10x Genomics, Inc.
CIK 1596800
VANCOUVER, A1
Position in TXG
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$37,892,188
+$17,969,787 QoQ
Shares Held
988,320
+5.3% QoQ
Ownership
0.759%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TXG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $242,623,303 across 27 Medical Devices names. TXG ranks #3 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
869,131 | $78,864,946 | |
| 2 | BSX |
Boston Scientific Corp
|
1,467,148 | $62,617,875 | |
| 3 | TXG |
10x Genomics, Inc.
This page
|
988,320 | $37,892,188 | |
| 4 | PHG |
Koninklijke Philips NV
|
563,724 | $15,327,654 | |
| 5 | SNN |
Smith & Nephew PLC
|
487,774 | $14,052,767 | |
| 6 | NVCR |
NovoCure Ltd
|
661,280 | $10,018,391 | |
| 7 | IRTC |
iRhythm Holdings, Inc.
|
42,314 | $5,033,250 | |
| 8 | AXGN |
Axogen, Inc.
|
67,118 | $3,100,180 |
All Filings in TXG
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,892,188 | 988,320 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $19,922,401 | 938,408 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $11,573,233 | 709,579 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,711,259 | 317,473 | Shares | Sole | 2025-11-13 | |
| 2022-12-31 | $914,097 | 25,085 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||